Lifevantage (LFVN) Gross Margin (2010 - 2026)
Lifevantage's (LFVN) quarterly Gross Margin came in at 524.49% in Q2 2026, up 44457.0% on a YoY basis from N/an in Q2 2025, and up 563.75% quarter-over-quarter from 79.02% in Q1 2026.
Powered by 
Analysis
Lifevantage (LFVN) Gross Margin (2010 - 2026) Analysis & Trends
Lifevantage (LFVN) has reported Gross Margin for 17 consecutive years, with 524.49% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 44457.0% year-over-year to 524.49%; the trailing twelve-month figure through Jun 2026 stood at 96.66% (up 1629.0% YoY), and the FY2026 full-year result was 77.56%, down 281.0% from the prior year.
- Gross Margin climbed to 524.49% in Q2 2026 per LFVN's latest filing, from 79.02% in the prior quarter.
- Across five years, Gross Margin topped out at 524.49% in Q2 2026 and bottomed at 74.0% in Q4 2025.
- Historically, Gross Margin has averaged 104.26% across 5 years, with a median of 79.91% in 2024.
- The sharpest annual moves came in 2025 and 2026: Gross Margin sank 653 bps in 2025, then surged 44457 bps in 2026.
- Over 5 years, Gross Margin stood at 78.09% in 2022, then advanced by 1 bps to 78.56% in 2023, then grew by 2 bps to 80.53% in 2024, then decreased by 8 bps to 74.0% in 2025, then surged by 609 bps to 524.49% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 524.49%, 79.02%, and 74.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.54 Bn | 69.17 Bn | 3.30 Bn | 61.48% |
| 2 | Kenvue | 34.15 Bn | 33.04 Bn | 2.30 Bn | 58.18% |
| 3 | Kimberly Clark | 32.75 Bn | 31.80 Bn | 1.60 Bn | 38.27% |
| 4 | Bath & Body Works | 3.74 Bn | 2.95 Bn | 692.00 Mn | 45.71% |
| 5 | Prestige Consumer Healthcare | 2.28 Bn | 2.22 Bn | - | - |
| 6 | Perrigo | 1.91 Bn | 1.52 Bn | 313.90 Mn | 30.69% |
| 7 | Herbalife | 1.28 Bn | 911.72 Mn | 1.03 Bn | 77.67% |
| 8 | Edgewell Personal Care | 1.22 Bn | 825.47 Mn | 242.50 Mn | 42.54% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Lifevantage | 79.78 Mn | 64.86 Mn | 33.04 Mn | 524.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 524.49% |
| Mar 31, 2026 | 79.02% |
| Dec 31, 2025 | 74.00% |
| Sep 30, 2025 | 79.51% |
| Jun 30, 2025 | 79.92% |
| Mar 31, 2025 | 80.98% |
| Dec 31, 2024 | 80.53% |
| Sep 30, 2024 | 79.90% |
| Jun 30, 2024 | 79.52% |
| Mar 31, 2024 | 78.92% |
| Dec 31, 2023 | 78.56% |
| Sep 30, 2023 | 80.18% |
| Jun 30, 2023 | 79.59% |
| Mar 31, 2023 | 80.24% |
| Dec 31, 2022 | 78.09% |
| Sep 30, 2022 | 80.80% |
| Jun 30, 2022 | 81.68% |
| Mar 31, 2022 | 80.69% |
| Dec 31, 2021 | 81.46% |
| Sep 30, 2021 | 82.28% |